Slides from Presentations
- Tancredi, Dan. Meta-analyses: Considerations for probiotics and prebiotics studies.
- VanMeter, John. Using neuroimaging to study the effects of probiotic and prebiotic on the human brain.
Plenary Session 1. Regulatory challenges to moving probiotics forward in the USA.
- Merenstein, Daniel. Introduction.
- Roller, Sarah. U.S. Regulation of Probiotics: Can FDA Make Room for Another Way?
- Marks, Peter. Regulatory perspectives on human research on probiotics.
- Hibberd, Patricia. Frontline perspectives from a physician
- Deshpande, Girish. Finding a solution: probiotics for premature infants.
Plenary Session 2. What’s needed to translate pro/prebiotics to clinical outcomes?
- Lyte, Mark. Evaluating the potential of probiotics and prebiotics for influencing brain function – from fetus to adults.
- Quigley, Eamonn. Influencing the liver and implications for obesity and metabolic syndrome.
Plenary Session 3. Modulating the microbiome.
- Marchesi, Julian. What evidence exists for a causal role of the microbiome in human health and disease? Bringing ‘omics techniques together.
- Dietert, Rodney. Health and disease aspects of the human microbiome.
- Lee, Yuan-Kun. How the microbiome is influenced by diet and ethnicity.
Late Breaking News
- Troup, John. Practitioner & patient education for the selection and use of effective probiotics
- Kiran, Thakur. Probiotic lactic acid bacteria as a vitamin supplier to human consumers
- Gibson, Glenn. What’s in a name?
- van Hemert, Saskia. Can probiotics be used as preventative strategy for depression?
- Reid, Gregor. Probiotics for preterm babies – the issues
- Rains, Tia. Egg Nutrition Center interests in joining ISAPP
- Nuutila, Pirjo. Metabolic disease, microbiota and imaging of intestinal metabolism
- Piche, Thierry. Translational approaches to study epithelial barrier integrity
- Singh, Satvinder. Propionate: friend or foe
- Ouwehand, Arthur. Probiotics provide public health and economic benefits to society
Discussion Group Summary slides.
- Technology transfer. Chair: Michael Cabana and Eric Claassen
- Prebiotics and oligosaccharides in the gut: who (is enriched), what (is the effect), where (do these effects occur), and how (are these effects ultimately manifested)? Chairs: Bob Hutkins and George Fahey
- Potential to employ probiotics/prebiotics for fetus and infants to improve well-being. Chairs: Seppo Salminen and Gregor Reid
- What is the future of probiotics in the USA? Regulatory challenges. Chairs: Dan Merenstein and Mary Ellen Sanders
- Intestinal barrier function – its role in GI disease, allergy, and other diseases. Chair: Eamonn Quigley and Todd Klaenhammer
- The microbiome response to pre/probiotics. Chairs: Karen Scott and Glenn Gibson